Title: A Comparative Study of Thyroid Profile in Individuals with and Without Metabolic Syndrome

Authors: Dr Subhasish Deb, Dr Amit Sarkar, Dr Somnath Dasgupta, Dr Ashish P Dudhe, Dr Agnibha Dutta

 DOI: https://dx.doi.org/10.18535/jmscr/v8i3.04

Abstract

   

Metabolic syndrome  is increasingly  recognised  as  emerging  threats  to  health  of  human  race. Thyroid hormones up regulate metabolic pathways relevant to resting energy expenditure. Obesity causes alteration in thyroid function tests. We compared the thyroid profiles of individuals with and without Metabolic Syndrome and assessed the possibility of obesity influencing the results. This is a cross sectional study which includes 200 patients above the age of 18 years attending the outpatient department of our institution from January 2015 to August 2016. They were divided into four groups where group 1 consists  of  patients with Metabolic syndrome and obesity, group 2 with Metabolic Syndrome without obesity, group 3 without Metabolic syndrome but obese and group 4 without Metabolic syndrome and non obese. The NCEP ATP III criteria was used for assessing Metabolic syndrome and revised consensus guidelines for Asian Indians was chosen to determine the Body Mass Index (BMI) for obesity. TSH, T4, T3 were measured as indicators of thyroid function. The difference in mean TSH levels between individuals with Metabolic Syndrome (3.84 ± 2.44uIU/L) and without Metabolic Syndrome (2.10±1.70uIU/L) was statistically significant (p = £ 0.05) while the mean T4 and T3 levels were comparable. Amongst individuals with metabolic syndrome ,difference of mean TSH between  obese and  non-obese group  was not significant (p=0.984). Individuals with Metabolic syndrome have a higher TSH level but normal T3 and T4 levels. This rise in TSH is independent of obesity.

Keywords: Metabolic syndrome, Thyroid profile.

References

  1. Reaven GM: Banting lecture 1988. Role of Insulin Resistance in Human Disease. Diabetes 1988 Dec; 37(12):1595-1607.
  2. Meigs JB, Wilson PWF, Nathan DM , D’Agostino RB Sr, Williams K, Haffner SM . Prevalence and Characteristics of the Metabolic Syndrome in the San Antonio  Heart and Framingham Offspring Studies. Diabetes  2003 Aug ; 52(8) : 2160-67.
  3. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G , Bonadonna RC, Muggeo M Metabolic syndrome: epidemiology and more extensive phenotypic  Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord 2003 Oct;  27(10): 1283-89.
  4. Salaroli LB, Barbosa GC, Mill JG , Molina MCB . Prevalence of metabolic syndrome in population-based study, Vitória, ES-Brazil. Arq Bras Endocrinol Metab 2007 Oct ; 51 (7): 1143-52.
  5. Ramachandran A, Snehalatha C, Satyavani  K, Sivasankari S , Vijay V. Metabolic  syndrome  in  urban  Asian Indian adults -- A  population  study  using  modified  ATP  III  criteria   . Diabetes  Res Clin Pract  2003; 60 (3):199- 204.
  6. Mohan V, Shanthirani S , Deepa R , Premalatha  G, Sastry  NG, Saroja  R . Intra-urban  differences  in  the prevalence  of  the  metabolic  syndrome  in  southern  India – The  Chennai  Urban  Population  Study (CUPS No.4) .Diabet Med 2001 ;18(4):280-87.
  7. Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K:  Prevalence of metabolic syndrome in an   Indian urban population. Int J Cardiol 2004, 97(2):257-61.
  8. Luboshitzky R, Aviv A, Herer P, Lavie L (2002) Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2002 ; 12(5): 421-25.
  9. Knudsen N, Laurberg P, Rasmussen LB, Bülow I, Perrild H, Ovesen L, Jørgensen T Small Differences in Thyroid Function May Be Important for Body Mass Index  and the Occurrence of Obesity in the Population. J Clin Endocrinol Metab 2005 July 1 ; 90(7): 4019-24
  10. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel  on Detection, Evaluation and Treatment of High  Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285(19):2486-97.
  11. Mishra A, Chowbey P, Makkar BM, Vikram NK,Wasir JS, Chadha D,Joshi S R,Sadikot S, Gupta R, Gulati S, Munjal YP. Consensus Statement  for  Diagnosis  of  Obesity, Abdominal  Obesity  and  the  Metabolic  Syndrome  for  Asian   Indians  and  Recommendations  for  Physical  Activity, Medical and  Surgical Management. J Assoc Physicians India. 2009 Feb ; 57 : 163-7.
  12. Stichel H, I’Allemand D, Gruters A. Thyroid Function and Obesity in Children and Adolescents. Horm Res 2000;54 (1):14-19.
  13. Kiortsis DN, Durack I, Turpin G. Effects of a low-calorie diet on resting metabolic rate and serum tri-iodothyronine levels in obese children. Eur J Pediatr 1999 May ; 158(6):446-50
  14. Ruhla S , Weickert MO , Arafat AM, Osterhoff M, Isken F, Spranger J, Schofl C, Pfeiffer AFH, Mohlig M, A high normal TSH is associated with the metabolic syndrome. Clin Endocrinol (oxf) 2010 March 25 ;72(5):696-701
  15. Lee YK , Kim JE, Oh HJ,Park KS, Kim SK,Park SW, Kim MJ,Cho YW . Serum TSH level in Healthy Koreans and the Association of TSH with Serum Lipid Concentration and Metabolic Syndrome. Korean J Intern Med 2011 Dec;26(4):432-9
  16. Bastemir M , Akin F , Alkis E , Kaptanoglu B . Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss Med Wkly 2007; 137(29-30): 431-4.
  17. Liu Y Y , Schultz J J, Brent G A. A Thyroid Hormone Receptor alpha gene mutation (P398H) Is Associated with Visceral Adiposity and Impaired Catecholamine stimulated Lipolysis in Mice. J Biol  Chem 2003; 278 (40):38913-20.
  18. Burman K D , Latham K R , Djuh Y-Y , Smallridge R C , Tseng Y-C L , Lukes Y G, Maunder R, Wartofsky L . Solubilized Nuclear Thyroid Hormone Receptors in Circulating Human Mononuclear Cell. J Clin Endocrinol Metab 1980 ; 51(1) : 106-16.
  19. Escobar-Morreale H F Obregon M J , Escobar del Ray F , Morreale de Escobar G. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomised rats. J Clin  Invest 1995 ; 96(6):2828-38.
  20. Maratou E, Hadjidakis DJ, Kollias A et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009;160(5):785-90.
  21. Dardano A, Ghiadoni L, Plantinga Y, Caraccio N, Bemi A, Duranti E, Taddei S, Ferrannini E, Salvetti A , Monzani F . Recombinant Human Thyrotropin Reduces  Endothelium- Dependent Vasodilation in Patients  Monitored  for ifferentiated Thyroid Carcinoma. J Clin  Endocrinol Metab 1 October 2006 ; 91(10): 4175-78.
  22. Antunes TT, Gagnon A, Chen B, Pacini F, Smith TJ, Sorisky A . Interleukin-6 release from human abdominal adipose cells is regulated by thyroid stimulating  hormone: effect of adipocyte differentiation  and  anatomic depot. Am J Physiol Endocinol Metab 2006 JUN 01;290 (6) :E1140-4.

Corresponding Author

Dr Amit Sarkar

Burdwan Medical College and Hospital, P.O. Burdwan, Pin – 713104, District – East Burdwan, West Bengal, India